NCI Outstanding Investigator Award (R35 Clinical Trial Optional)
Closed Posted
- Opportunity number
- RFA-CA-22-045
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Up to $600,000
Opportunity facts
- Assistance listings
-
- 93.393 Cancer Cause and Prevention Research
- 93.394 Cancer Detection and Diagnosis Research
- 93.395 Cancer Treatment Research
- 93.396 Cancer Biology Research
- 93.397 Cancer Centers Support Grants
- 93.398 Cancer Research Manpower
- 93.399 Cancer Control
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- Higher Education Inst. (Private)
- Tribal Governments (Federally Recognized)
- Special District Governments
- Tribal Organizations (Not Federally Recognized)
- For Profit Organizations
- Non-501(c)(3) Nonprofits
- County Governments
- Higher Education Inst. (Public)
- Other
- 501(c)(3) Nonprofits
- City/Township Governments
- Public or Indian Housing Auth.
- Small Businesses
- Independent School Districts
- State Governments
- Full announcement
Opportunity details come from Grants.gov. Updated .
Synopsis
This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research.The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA.It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research.
Files
| File | Type | Posted |
|---|---|---|
| RFA-CA-22-045-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity